Boc-GABA-OH

CAS No. 57294-38-9

Boc-GABA-OH( —— )

Catalog No. M26914 CAS No. 57294-38-9

Boc-GABA-OH is a PROTAC linker that can be used to synthesize UNC6852, an EED-targeted PROTAC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Boc-GABA-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    Boc-GABA-OH is a PROTAC linker that can be used to synthesize UNC6852, an EED-targeted PROTAC.
  • Description
    Boc-GABA-OH is a PROTAC linker that can be used to synthesize UNC6852, an EED-targeted PROTAC.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VEGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    57294-38-9
  • Formula Weight
    203.238
  • Molecular Formula
    C9H17NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)OC(=O)NCCCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hilberg F, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumorefficacy. Cancer Res. 2008 Jun 15;68(12):4774-82.
molnova catalog
related products
  • NADP sodium salt

    NADP sodium salt is a coenzyme that is widely distributed in living matter. Participates in oxidation-reduction reactions.

  • 1-(2-hydroxyethyl)th...

    1-(2-hydroxyethyl)thymine (2,4(1H,3H)-Pyrimidinedione, 1-(2-hydroxyethyl)-5-methyl-) is a marine derived natural products found in Zoanthus sp.

  • Atracurium besylate

    Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.